Phantomics

Phantomics is a Korea South-based startup founded in 2019 with a mission to revolutionize healthcare through innovative imaging technology. The company's slogan, "Prospective healthcare solution to lead your better healthy life," reflects its commitment to providing non-invasive and user-friendly diagnostic healthcare solutions. With a focus on AI, Phantomics aims to alleviate the burdens faced by physicians and improve diagnostic accuracy. Led by a team of experts in cardiology, radiology, medical imaging, and artificial intelligence, Phantomics has developed the Myomics series, an AI-driven cardiac MR solution that automates the analysis and quantification of cardiac MR images. This technology empowers physicians to expedite medical diagnoses and enhance patient treatment, demonstrating the company's potential to shape the future of medical imaging. In January 2023, Phantomics successfully secured a Series A investment from DAYLI Partners, signaling confidence in the company's vision and achievements. This investment will enable Phantomics to further develop its cutting-edge healthcare solutions and expand its impact on the field of diagnostic imaging technology. As Phantomics continues on its path to enhance medical imaging and harness the power of AI, it remains committed to leveraging its expertise and capabilities to promote healthier lives for humankind.